Literature DB >> 19343533

Fabry disease in a patient with Turner syndrome.

R Brouns1, F Eyskens, K De Boeck, C Ceuterick-de Groote, M Van den Broeck, C Van Broeckhoven, P P De Deyn.   

Abstract

We report a unique case with co-occurrence of Turner syndrome and Fabry disease (OMIM #301500). The latter is a rare X-linked lysosomal storage disease that is characterized by partial or complete deficiency of alpha-galactosidase A (GLA; EC 3.2.1.22) following mutations in the gene (GLA) localized at Xq22.1. Accumulation of metabolic intermediates can occur in many tissues and leads to severe morbidity, especially due to renal failure, cardiac involvement and stroke. It is well established that hemizygous male mutation carriers with Fabry disease are generally more severely affected than heterozygous female mutation carriers, but disabling clinical features and disease progression often occur in female Fabry patients as well. The majority of this patient's cells are of the 45,X type, making her a hemizygous GLA mutation carrier displaying a very severe Fabry disease phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343533     DOI: 10.1007/s10545-009-1035-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Fabry disease: 20 novel GLA mutations in 35 families.

Authors:  D Blaydon; J Hill; B Winchester
Journal:  Hum Mutat       Date:  2001-11       Impact factor: 4.878

Review 2.  Electron microscopic features of skin in neurometabolic disorders.

Authors:  C Ceuterick; J J Martin
Journal:  J Neurol Sci       Date:  1992-10       Impact factor: 3.181

3.  A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome).

Authors:  C E FORD; K W JONES; P E POLANI; J C DE ALMEIDA; J H BRIGGS
Journal:  Lancet       Date:  1959-04-04       Impact factor: 79.321

Review 4.  Turner's syndrome.

Authors:  Virginia P Sybert; Elizabeth McCauley
Journal:  N Engl J Med       Date:  2004-09-16       Impact factor: 91.245

5.  Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone.

Authors:  Leandro Soriano-Guillen; Joël Coste; Emmanuel Ecosse; Juliane Léger; Maïté Tauber; Sylvie Cabrol; Marc Nicolino; Raja Brauner; Jean-Louis Chaussain; Jean-Claude Carel
Journal:  J Clin Endocrinol Metab       Date:  2005-07-05       Impact factor: 5.958

Review 6.  Narrative review: Fabry disease.

Authors:  Joe T R Clarke
Journal:  Ann Intern Med       Date:  2007-03-20       Impact factor: 25.391

7.  Turner's syndrome and hearing disorders in women aged 16-34.

Authors:  M Hultcrantz; L Sylvén
Journal:  Hear Res       Date:  1997-01       Impact factor: 3.208

8.  The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

Authors:  C Whybra; C Kampmann; F Krummenauer; M Ries; E Mengel; E Miebach; F Baehner; K Kim; M Bajbouj; A Schwarting; A Gal; M Beck
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

9.  Prevalence of lysosomal storage disorders.

Authors:  P J Meikle; J J Hopwood; A E Clague; W F Carey
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

  9 in total
  1 in total

1.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.